Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Operating Expenses (2016 - 2026)

Ironwood Pharmaceuticals' Other Operating Expenses history spans 12 years, with the latest figure at -$252000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 445.21% to -$252000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $20.3 million, a 681.22% increase, with the full-year FY2025 number at $20.3 million, up 681.22% from a year prior.
  • Other Operating Expenses hit -$252000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for IRWD hit a ceiling of $1.1 billion in Q2 2023 and a floor of -$252000.0 in Q4 2025.
  • Historically, Other Operating Expenses has averaged $105.9 million across 3 years, with a median of $2.1 million in 2024.
  • The widest YoY moves for Other Operating Expenses: up 13650.0% in 2025, down 445.21% in 2025.
  • Tracing IRWD's Other Operating Expenses over 3 years: stood at $5.6 million in 2023, then crashed by 98.7% to $73000.0 in 2024, then crashed by 445.21% to -$252000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for IRWD at -$252000.0 in Q4 2025, $2.2 million in Q3 2025, and -$250000.0 in Q2 2025.